Clinical Trial Update: Milrinone in Congenital Diaphragmatic Hernia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating milrinone for congenital diaphragmatic hernia with persistent pulmonary hypertension of the newborn has completed enrollment and post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Diaphragmatic Hernia
• Hypoxemic Respiratory Failure
• Persistent Pulmonary Hypertension of the Newborn
• Pulmonary Hypoplasia

Drugs mentioned

• Milrinone (milrinone)

Snippet

Sponsor: NICHD Neonatal Research Network | Conditions: Congenital Diaphragmatic Hernia, Persistent Pulmonary Hypertension of the Newborn | Phase 2 | Status: COMPLETED | Results posted: 2025-11-06